Загрузка...
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Increasing evidence suggests that signaling through the prolactin/prolactin receptor axis is important for stimulation the growth of many cancers including glioblastoma multiforme, breast and ovarian carcinoma. Efficient inhibitors of signaling have previously been developed but their applicability...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504076/ https://ncbi.nlm.nih.gov/pubmed/31063493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215831 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|